Related Experiment Video
Updated: Apr 16, 2026
Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
Published on: June 11, 2014
Evaluation of chemotherapeutics in a three-dimensional breast cancer model
Carrie J Lovitt1, Todd B Shelper, Vicky M Avery
1Discovery Biology, Eskitis Institute for Drug Discovery, Griffith University, Building N27, Brisbane Innovation Park, Nathan, QLD, 4111, Australia, carrie.lovitt@griffithuni.edu.au.
Purpose:
Utilization of miniaturized three-dimensional (3D) cell culture-based assays enables investigation into the anticancer activity of drug candidates and further elucidation of the anticancer profile of standard-of-care chemotherapeutic agents against tumor cells. Drug discovery assays established using 3D cell culture, which better recapitulate the tumor microenvironment, may more accurately reflect the antitumor activity of compounds.
Methods:
Several standard-of-care anticancer drugs, epirubicin, paclitaxel and vinorelbine, were evaluated against a panel of breast cancer cell lines grown in a 3D cell culture microenvironment in the presence of extracellular matrix. A comparison of this antitumor activity in 3D conditions was made with that observed in traditional two-dimensional (2D) monolayer conditions.
Results:
Examination of the above mentioned drugs against breast tumor cells cultured in 3D conditions demonstrated significantly altered potency and efficacy in comparison with cells propagated in a 2D monolayer system. The differences observed were cell line-dependent and drug-specific; the triple-negative cell line MDA-MB-231 and the endocrine receptor-positive cell line MCF-7 consistently displayed resistance to therapeutics with distinct modes of action (i.e., topoisomerase II and microtubules) in 3D cell culture in comparison with ErbB2 receptor-positive BT-474 cells.
Conclusion:
The data presented herein demonstrates the cellular viability and physical changes observed within the 3D spheroid following exposure to drug, which is not always reflected in 2D cell culture models.
Insights
Three-dimensional (3D) cell cultures reveal distinct anticancer drug efficacy compared to traditional 2D models. This highlights the importance of 3D models for accurate drug response prediction in cancer research.
Area of Science:
- Oncology
- Cell Biology
- Drug Discovery
Background:
- Three-dimensional (3D) cell culture models offer a more realistic tumor microenvironment than traditional 2D cultures.
- Accurate prediction of anticancer drug efficacy is crucial for drug discovery and development.
Purpose of the Study:
- To investigate the anticancer activity of standard chemotherapeutic agents using 3D cell culture.
- To compare drug efficacy in 3D cultures versus 2D monolayer systems.
Main Methods:
- Standard anticancer drugs (epirubicin, paclitaxel, vinorelbine) were tested against breast cancer cell lines in 3D cultures with extracellular matrix.
- Antitumor activity in 3D was compared to results from 2D monolayer cultures.
Main Results:
- Drug potency and efficacy were significantly altered in 3D cultures compared to 2D.
- Differences were cell line- and drug-specific, with notable resistance observed in triple-negative (MDA-MB-231) and endocrine receptor-positive (MCF-7) cells in 3D.
Conclusions:
- 3D cell culture models reveal cellular viability and physical changes not always apparent in 2D models.
- 3D spheroid assays provide a more accurate reflection of drug response in a tumor microenvironment.
